Sanofi has said it will press ahead with regulatory filings for atopic dermatitis (AD) candidate amlitelimab after reporting ...

"The addition of relacorilant to nab-paclitaxel, a trusted and effective chemotherapy, is positioned to become a new standard ...

The cash injection will also allow Corxel to start phase 2 testing in type 2 diabetes and help to fund a phase 3 programme in ...

Click Therapeutics is well on its way to doing both – and in a sit down interview at the Informa Biotech Showcase in San ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

Pharma and advanced therapy manufacturing will only grow more complex in science, regulation, and global scale. But the ...

The EVA for DHTs used by people with hip and knee osteoarthritis (PDF) recommends eight products, namely: GetUBetter; Good ...

J&J is predicting 2026 revenues will be between $99.5 billion and $100.5 billion, up from just over $94 billion in 2025.

Amazon has become the latest tech company to introduce an AI-powered assistant that is designed to provide health guidance ...

Roche's Gazyvaro, a drug that can restore kidney function in people living with lupus nephritis, has been cleared for use by ...

GSK gets an entry in the list with Exdensur (depemokimab), a twice-yearly injectable IL-5 inhibitor for severe asthma, which ...

The WHO has been working over the past year to try to get the Trump administration to change course, and Director General ...